FTC’s Substantiation Bar: TriVita Inc. (July 2014)
Searching for trends in recent FTC consent orders and related motions
In its July 15, 2014, FTC’s stipulated order for permanent injunction would ban the maker of Nopal cactus (prickly pear) drinks and products from making inflammation-related, pain-relief, and other claims unless the firm has “human clinical testing of the Covered Product or of an Essentially Equivalent Product that is sufficient in quality and quantity, based on standards generally accepted by experts in the relevant field, when considered in the light of the entire body of relevant and reliable scientific evidence, to substantiate that the representation is true. Such testing shall: (1) be randomized, double-blind, and placebo-controlled; and (2) be conducted by researchers qualified by training and experience to conduct such testing.” However, the FTC does not specify how many trials are needed.
FTC Requirement: Human studies (but doesn’t specify number of studies)
<<Previous Next>>
Jennifer Grebow
Editor-in-Chief
Nutritional Outlook magazine jennifer.grebow@ubm.com
Photo © iStockphoto.com/Laspi
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.
